🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Michael Feigh

Gubra (Denmark)

ORCID: 0000-0001-5274-8799

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis”.

Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis

Nature Metabolism(2020)10.1038/s42255-020-0209-6

N/A

0DataRank · unranked

258 citations

Rhianna C. Laker, KARLY M. MATHER, Arkadiusz Nawrocki, Stephanie Oldham, Brandon B. Boland +15 more

The Selective Peroxisome Proliferator‐Activated Receptor Gamma Modulator CHS‐131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis

Hepatology Communications(2020)10.1002/hep4.1558

N/A

0DataRank · unranked

19 citations

Aditya Joshi, Natia Peradze, Konstantinos Stefanakis, Georgia Li, Michael Feigh +5 more

Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non‐alcoholic steatohepatitis

Liver International(2021)10.1111/liv.14888

N/A

0DataRank · unranked

38 citations

Konstantinos Stefanakis, Michael Feigh, Sanne Skovgård Veidal, Christos S. Mantzoros, Nikolaos Perakakis

Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH

International Journal of Molecular Sciences(2021)10.3390/ijms22126332

N/A

0DataRank · unranked

33 citations

Pavlina Chrysafi, Michael Feigh, Sanne Skovgård Veidal, Christos S. Mantzoros, Nikolaos Perakakis

Structurally‐engineered fatty acid 1024 (SEFA‐1024) improves diet‐induced obesity, insulin resistance, and fatty liver disease

Lipids(2022)10.1002/lipd.12351

N/A

0DataRank · unranked

4 citations

Bennet S. Cho, Lumeng J. Yu, Amy Pan, Victoria H. Ko, Duy T. Dao +7 more

An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

Nature Metabolism(2024)10.1038/s42255-024-01043-6

N/A

0DataRank · unranked

237 citations

Ioannis Kamzolas, Lea Mørch Harder, Fiona Oakley, Christian Trautwein, Maximilian Hatting +83 more